From microbe to market: how new vaccines are developed and approved in Canada
Researchers
Kelley Lee, Jillian Kohler
Key takeaways
- Every new vaccine used in Canada moves through six connected stages involving thousands of people: discovery, testing in the lab, testing with people, review for approval, production and distribution, and ongoing safety monitoring.
- An end-to-end resource on Canada’s pipeline can help demystify how vaccines are made, highlight the people behind the process, and serve as a foundation for new resources.
- Examining the social and ethical questions at each stage can help people understand the strengths of Canada’s vaccine pipeline.
Overview
What does the vaccine development process entail? What scientific, ethical, regulatory, industry and public health perspectives shape this process?
As identified in the Vaccine Behaviours, Attitudes, and Perspectives (VBAP) survey, most people in Canada have limited knowledge how vaccines are developed but would be more willing to be vaccinated if this information was made more readily available.
However, understanding how new vaccines are developed has become more challenging because of the increased volume, but variable quality, of available information. Information is currently fragmented across numerous organizations and websites with no centralized Canadian resource available.
From microbe to market: A guide to the therapeutic pipeline for new vaccines in Canada
Researchers have developed a guide to describe how new vaccines are developed, tested, reviewed and approved, manufactured, and eventually used and monitored for safety and effectiveness in Canada.
This multi-stage process is known as the “therapeutic pipeline.” Each stage involves different people and processes contributing to safe and effective vaccines.

Learn more: